An autopsy case study of lymphocytic hypophysitis induced by nivolumab treatment for esophageal malignant melanoma

2021 ◽  
Author(s):  
Naota Okabe ◽  
Takaaki Kobayashi ◽  
Junji Furuse ◽  
Masachika Fujiwara ◽  
Hiroshi Kamma
1999 ◽  
Vol 20 (5) ◽  
pp. 336-339 ◽  
Author(s):  
Gadi Fishman ◽  
Dov Ophir

2017 ◽  
Vol 2017 ◽  
pp. 1-4 ◽  
Author(s):  
Hani Katerji ◽  
John M. Childs ◽  
Laura E. Bratton ◽  
Christian G. Peyre ◽  
Aaron R. Huber

Primary esophageal malignant melanoma (MM) is rare and extremely aggressive. For pathologists, it can be challenging to diagnose and differentiate from other poorly differentiated malignant neoplasms in the esophagus. Complicating this fact, MM can have divergent differentiation and express nonmelanocytic immunohistochemical markers including epithelial markers (cytokeratins) and rarely neuroendocrine markers. Lack of awareness of this fact by a pathologist can lead to an erroneous diagnosis and delay treatment for an already aggressive disease. Herein, we report a case of primary esophageal malignant melanoma with aberrant CD56 expression without accompanying synaptophysin or chromogranin expression.


Esophagus ◽  
2015 ◽  
Vol 12 (2) ◽  
pp. 158-169 ◽  
Author(s):  
Hiroyasu Makuuchi ◽  
Kaiyo Takubo ◽  
Akio Yanagisawa ◽  
Soichiro Yamamoto

2005 ◽  
Vol 19 (3) ◽  
pp. 201-205 ◽  
Author(s):  
Jun Ogata ◽  
Kiminobu Yonemura ◽  
Kazumi Kimura ◽  
Chikao Yutani ◽  
Kazuo Minematsu

2013 ◽  
Vol 88 (9) ◽  
pp. 824-824 ◽  
Author(s):  
Binod Dhakal ◽  
Kristinza Giese ◽  
Linus Santo-Thomas ◽  
Joshua J. Field

Sign in / Sign up

Export Citation Format

Share Document